Exozymes Inc. (NASDAQ:EXOZ – Get Free Report) shares traded up 3.9% during trading on Tuesday . The stock traded as high as $13.99 and last traded at $13.96. 1,355 shares were traded during trading, a decline of 92% from the average session volume of 17,489 shares. The stock had previously closed at $13.44.
Exozymes Price Performance
The stock has a 50 day simple moving average of $12.52.
Exozymes (NASDAQ:EXOZ – Get Free Report) last released its earnings results on Monday, May 12th. The company reported ($0.22) EPS for the quarter.
Exozymes Company Profile
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
See Also
- Five stocks we like better than Exozymes
- Find and Profitably Trade Stocks at 52-Week Lows
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- Using the MarketBeat Stock Split Calculator
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
- Want to Profit on the Downtrend? Downtrends, Explained.
- Government Mandate Sends eVTOL Stocks Flying
Receive News & Ratings for Exozymes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exozymes and related companies with MarketBeat.com's FREE daily email newsletter.
